Harvard professor turns to private equity to counter Trump research cuts
Under the deal announced Monday, İş Private Equity, a Turkish firm, has committed $39 million to a laboratory run by Gökhan Hotamışlıgil, a professor of genetics and metabolism at the T.H. Chan School of Public Health. The firm, which is a branch of Turkey's İşbank Group, also plans to invest an undisclosed amount of money in any drug candidates that come out of Hotamışlıgil's laboratory and are moved into a new biotech called Enlila.
It's a relatively modest deal, in the scope of investment banking. But the collaboration provides much-needed capital at a time when the model for funding scientific research has been thrown into chaos.
Advertisement
In the first six months of the Trump administration, government officials terminated at least
Advertisement
In all,
Plans for the İş Private Equity collaboration pre-date the Trump administration's science grant retrenchment. Talks began last year, when Hotamışlıgil traveled to Turkey — where he was born and attended university — for a symposium celebrating İşbank Group's centennial. The event was filled with Nobel laureates, entrepreneurs, and others discussing the future of Turkey.
Hotamışlıgil gave a presentation at the event detailing his experience as a scientist and his decades-long work exploring fatty acid binding proteins, or FABPs. This hormone is produced in fat cells and secreted into the blood, where it interacts with proteins to form a substance called fabkin. Elevated levels of fabkin are linked to obesity,
The presentation caught the attention of İşbank's chief executive.
Financing scientific research has always been a challenge, as Hotamışlıgil detailed to the İşbank Group event crowd. It's not easy to explore scientific unknowns while scrounging up grants and other capital.
'In the past, we were complaining about the principles of funding, which overwhelmingly tilted toward more conservative, more guaranteed outcomes… Then, suddenly, there was no funding,' Hotamışlıgil told STAT. Even now, Hotamışlıgil said he is shocked that a country like the U.S. would pull back its scientific financing so drastically, given how much success it's lent to large corporations and research institutions that elicit international envy.
Advertisement
The federal cuts have plunged many Chan School staff and faculty into cycles of grief and anger, said Amanda Spickard, the associate dean for research strategy and external affairs. They're now emerging from the daze to brainstorm new ways of replacing lost research dollars.
In a letter sent out last week, the school's dean of faculty, Andrea Baccarelli, laid out an initial slate of strategies for replacing lost funding, including asking corporate partners to make $100,000 gifts to support Ph.D. students and post-doctorate fellows. The idea has been well-received by executives in need of highly trained employees, said Sarah Branstrator, managing director of academic strategy and research partnerships at the Chan School.
School officials are also hopeful that the İşbank collaboration could be the first of multiple privately financed labs.
There have been isolated examples in which investment firms have financed specific university centers or research projects, often for preferential access to any new scientific innovations that come out of the laboratories.
Just across the Charles River from the Chan School, Harvard's Wyss Institute has spent the last five years working with an affiliate of the science-focused VC firm Northpond Ventures. Northpond initially committed $12 million to the alliance in 2020, and has made
New York investment firm Deerfield Management has been much more aggressive in funding early-stage research. It has committed around $390 million to collaborations with
Advertisement
Hotamışlıgil's lab may be a unique case, as metabolism has become a hot area of drug development, thanks to the success of Eli Lilly and Novo Nordisk's GLP-1 weight loss medications. Obesity-focused startups are still raking in
Meanwhile, other areas of public health research, like infectious diseases and vaccines, are a
'It is probably too optimistic to say that government funding could completely be replaced. Government funding is really crucial to keep science as its engine. Having said that, for the school faculty, there are incredible opportunities, in my view,' Hotamışlıgil said. '[This] gives some hope that there's also some alternative ways that we can support science.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
20 minutes ago
- New York Post
Trump warns ‘everyone should immediately evacuate Tehran' in ominous Truth Social post
President Trump warned that 'everyone' in Tehran should 'immediately evacuate' in a Monday night Truth Social post that also criticized Iran's decision not to enter into a nuclear deal. 'Iran should have signed the 'deal' I told them to sign. What a shame, and waste of human life. Simply stated, IRAN CAN NOT HAVE A NUCLEAR WEAPON. I said it over and over again! Everyone should immediately evacuate Tehran!' Trump wrote in the post. Israeli officials also called for those in Tehran to evacuate earlier Monday ahead of its continued military campaign against Iran, which has included slews of missile exchanges between the conflicting countries. Monday marked the fourth day of military action after Israel originally launched multiple missiles aimed at Iran's nuclear facilities and military leadership last Friday. On Sunday, Trump said that it is 'possible' the US could get involved in the conflict. There are roughly 9.5 million people in Tehran. This is a breaking story. Please check back for more information.
Hamilton Spectator
20 minutes ago
- Hamilton Spectator
Judge rules some NIH grant cuts illegal, saying he's never seen such discrimination in 40 years
WASHINGTON (AP) — A federal judge ruled Monday it was illegal for the Trump administration to cancel several hundred research grants, adding that the cuts raise serious questions about racial discrimination. U.S. District Judge William Young in Massachusetts said the administration's process was 'arbitrary and capricious' and that it did not follow long-held government rules and standards when it abruptly canceled grants deemed to focus on gender identity or diversity, equity and inclusion. In a hearing Monday on two cases calling for the grants to be restored, the judge pushed government lawyers to offer a formal definition of DEI, questioning how grants could be canceled for that reason when some were designed to study health disparities as Congress had directed. Young, an appointee of Republican President Ronald Reagan, went on to address what he called 'a darker aspect' to the cases, calling it 'palpably clear' that what was behind the government actions was 'racial discrimination and discrimination against America's LGBTQ community.' After 40 years on the bench, 'I've never seen government racial discrimination like this,' Young added. He ended Monday's hearing saying, 'Have we no shame.' During his remarks ending the hearing, the judge said he would issue his written order soon. Young's decision addresses only a fraction of the hundreds of NIH research projects the Trump administration has cut — those specifically addressed in two lawsuits filed separately this spring by 16 attorneys general, public health advocacy groups and some affected scientists. A full count wasn't immediately available. While Young said the funding must be restored, Monday's action was an interim step. The ruling, when formally issued, is expected to be appealed. The Trump administration didn't immediately respond to a request for comment. While the original lawsuits didn't specifically claim racial discrimination, they said the new NIH policies prohibited 'research into certain politically disfavored subjects.' In a filing this month after the lawsuits were consolidated, lawyers said the NIH did not highlight genuine concerns with the hundreds of canceled research projects studies, but instead sent 'boilerplate termination letters' to universities. The topics of research ranged widely, including cardiovascular health, sexually transmitted infections, depression, Alzheimer's and alcohol abuse in minors, among other things. Attorneys cited projects such as one tracking how medicines may work differently in people of ancestrally diverse backgrounds, and said the cuts affected more than scientists — such as potential harm to patients in a closed study of suicide treatment. Lawyers for the federal government said in a court filing earlier this month that NIH grant terminations for DEI studies were 'sufficiently reasoned,' adding later that 'plaintiffs may disagree with NIH's basis, but that does not make the basis arbitrary and capricious.' The NIH, lawyers argued, has 'broad discretion' to decide on and provide grants 'in alignment with its priorities' — which includes ending grants. Monday, Justice Department lawyer Thomas Ports Jr. pointed to 13 examples of grants related to minority health that NIH either hadn't cut or had renewed in the same time period — and said some of the cancellations were justified by the agency's judgement that the research wasn't scientifically valuable. The NIH has long been the world's largest public funder of biomedical research. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
San Francisco Chronicle
20 minutes ago
- San Francisco Chronicle
Jury finds MyPillow founder defamed former employee for a leading voting equipment company
DENVER (AP) — A federal jury in Colorado on Monday found that one of the nation's most prominent election conspiracy theorists, MyPillow founder Mike Lindell, defamed a former employee for a leading voting equipment company after the 2020 presidential election. The employee, Eric Coomer, was awarded $2.3 million in damages. He had sued after Lindell called him a traitor and accusations about him stealing the election were streamed on Lindell's online media platform. Coomer was the security and product strategy director at Denver-based Dominion Voting Systems, whose voting machines became the target of elaborate conspiracy theories among allies of President Donald Trump, who continues to falsely claim that his loss to Democrat Joe Biden in 2020 was due to widespread fraud. Dominion won a $787 million settlement in a defamation lawsuit it filed against Fox News over its airing of false claims against the company and has another lawsuit against the conservative network Newsmax. Newsmax apologized to Coomer in 2021 for airing false allegations against him. Coomer said during the two-week Lindell trial that his career and life were destroyed by the statements. His lawyers said Lindell either knew the statements were lies, or conveyed them recklessly without knowing if they were true. Lindell's lawyers denied the claims and said his online platform, formerly known as Frankspeech, is not liable for statements made by others. Lindell said he went to trial to draw attention to the need to get rid of electronic voting machines that have been targeted in a web of conspiracy theories. He said he used to be worth about $60 million before he started speaking out about the 2020 election and is now $10 million in debt. Reviews, recounts and audits in the battleground states where Trump contested his loss in 2020 all affirmed Democrat Joe Biden's victory. Trump's attorney general at the time said there was no evidence of widespread fraud, and Trump and his allies lost dozens of court cases seeking to overturn the result. Lindell stuck by his false claims that the 2020 presidential election was stolen during the trial, but did not call any experts to present evidence of his claims. Lindell said his beliefs that the 2020 election was tainted by fraud were influenced by watching the 2020 HBO documentary 'Kill Chain' and by the views of Trump's former national security adviser, Michael Flynn. In an interview for a documentary Lindell made in 2021, Flynn said foreign interference was going to happen in U.S. elections, and Lindell said he had no reason to doubt the claim since Flynn had worked for both political parties in intelligence. Lindell distanced himself from an account by a Colorado podcaster who claimed to have heard a conference call from the anti-fascist group Antifa before the 2020 election. The podcast claimed that on the call someone named Eric from Dominion said he would make sure that Trump would not win, a story that was recounted on Frankspeech during a 2021 event. Lindell said he only learned about that during the trial. Lindell said he never accused Coomer of rigging the election, but he did say he was upset because he said Newsmax blocked him from being able to go on air to talk about voting machines after it apologized to Coomer. Coomer denied there was any such deal to block Lindell under his agreement with the network. Coomer's lawyers tried to show how their client's life was devastated by the conspiracy theories spreading about him. Lindell was comparatively late to seize on Coomer, not mentioning him until February 2021, well after his name had been circulated by other Trump partisans. Coomer said the conspiracy theories cost him his job, his mental health and the life he'd built and said Lindell's statements were the most distressing of all. He specifically pointed to a statement on May 9, 2021, when Lindell described what he believed Coomer had done as 'treason.' Lindell's attorneys argued that Coomer's reputation was already in tatters by the time Lindell mentioned him. They said that was partly because of Coomer's own Facebook posts disparaging Trump, which the former Dominion employee acknowledged were 'hyperbolic' and had been a mistake. Lindell denied making any statements he knew to be false about Coomer and testified that he has called many people traitors. His lawyers argued the statements were about a matter of public concern — elections — and therefore protected by the First Amendment.
